ESR1 and breast cancer: The unaromatizable androgen Dihydrotestosterone (DHT) and the synthetic agonist of AR Mibolerone (Mb) inhibit cell proliferation and trigger apoptosis in ER+ breast cancer cells by activating AR [35,41].